Eligo Bioscience values collaborations and partnerships with pharmaceutical leaders, clinical organizations, academic laboratories and funding agencies as a way to accelerate the development of Eligobiotics® in microbiome-related diseases.
Eligo Bioscience is frequently communicating with and interested to hear from potential industry partners around indications for which selective killing or functionalization of microbial populations may be useful.
If you would like information on partnering, contact us at li[email protected]
Eligo Bioscience is always looking to collaborate with academic researchers & thought leaders to better understand and elucidate the role of microbes in human health and disease.
If you are an academic and are interested in collaborating, please contact us a [email protected]